Custom Crystal for First-Patient-Dosed Milestone

Crystal pill commemorative marking the first patient dosed by cancer treatment ACR-2316

Capsule-themed custom crystal commemoratng the first patient dosed stage in the development of ACR-2316. The cancer treatment was developed by Acrivon Therapeutics, a Watertown, Massachusetts-based biopharmaceutical company. (24AKL397)